News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news

Show

From To
Treatment for women
Pregnancy is a Missed Opportunity for HIV-Infected Women to Gain Control Over their Condition

Pregnancy could be a turning point for HIV-infected women, when they have the opportunity to manage their infection, prevent transmission to their new baby and enter a long-term pattern of maintenance of HIV care after giving birth—but most HIV-infected women aren’t getting that chance. That is the major message from a pair of new studies in Philadelphia, one published early online this month in the journal Clinical Infectious Diseases, and the other published in July in PLOS ONE.

Published
26 August 2015
From
Drexel Now
Treatment for women
WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV

A study of antiretroviral treatment specifically for women with HIV showed that a single-tablet regimen containing the integrase inhibitor elvitegravir suppressed the virus better than a regimen

Published
06 August 2015
By
Liz Highleyman
Prevention of mother-to-child transmission
Intensification of antiretroviral therapy reduces risk of late-term mother-to-child HIV transmission

Maternal and infant antiretroviral therapy (ART) intensification is very effective in preventing HIV transmission during labour and birth in pregnant women with HIV in Thailand who present late

Published
29 July 2015
By
Carole Leach-Lemens
Contraception
Implant and injectable hormonal contraception most effective methods for women living with HIV

Hormonal contraceptive methods are highly effective in reducing the risk of pregnancy in women living with HIV whether on antiretroviral therapy (ART) or not, according to an evaluation

Published
29 July 2015
By
Carole Leach-Lemens
Prevention of mother-to-child transmission
Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy

Combination antiretroviral therapy containing the integrase inhibitor raltegravir (Isentress) appears safe and effective and may be an attractive option for treatment for pregnant women with HIV –

Published
28 July 2015
By
Liz Highleyman
Starting treatment
Gender difference in vital cell count of HIV patients

Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster.

Published
10 June 2015
From
Science Daily
Prevention of mother-to-child transmission
7-country study shows triple-drug combination superior for preventing infant HIV infection

Implementing the World Health Organization (WHO) recommendation of three-drug antiretroviral treatment during pregnancy leads to a significantly lower rate of mother-to-child HIV transmission, a 7-country randomised study has

Published
25 February 2015
By
Keith Alcorn
Microbicides
Looking to a New Era for Women's HIV Prevention: Zeda Rosenberg

Zeda Rosenberg, Chief Executive Offiver of the International Partnership for Microbicides, says: "While there is much progress to celebrate in HIV treatment and prevention, protecting women remains a major challenge. AIDS is the number-one killer of women ages 15 to 44 worldwide. Women are biologically more vulnerable to infection and face deep-rooted gender inequities that increase their risk. In sub-Saharan Africa, where the epidemic has taken the greatest toll, young women are at least twice as likely to contract HIV as young men."

Published
26 November 2014
From
Huffington Post
Treatment for women
Is A Study Of HIV Treatment For Mothers In Africa Unethical?

A global health controversy erupted this summer when the prominent scientific journal Nature ran an article entitled “HIV trial attacked.” Within, commentators squared off over whether a huge ongoing study provides suboptimal and thus unethical treatment options to mothers with HIV in the developing world.

Published
02 October 2014
From
Health Affairs (blog)
Prevention of mother-to-child transmission
Pregnant women need more support on looking after their own health after childbirth – could help retention in Option B+ programmes

Many women living with HIV believe that HIV care for the mother’s own health is unimportant once the baby is born, especially if the infant tests HIV

Published
10 September 2014
By
Roger Pebody
← Prev1...34567...14Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.